| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/26/2009 | CA2697020A1 Method of producing plant extract formulations |
| 02/26/2009 | CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/25/2009 | EP2028186A2 Hepatitis C inhibitor tri-peptides |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027863A1 Intestinal eosinophil-suppressing composition |
| 02/25/2009 | EP2027852A1 Adhesive compositions for the treatment of xerostoma |
| 02/25/2009 | EP2027120A2 Mglur5 modulators i |
| 02/25/2009 | EP2027085A1 Prostaglandin ep4 agonists |
| 02/25/2009 | EP1691626B1 Food and feed supplement and its use |
| 02/25/2009 | EP1446023B1 Foodstuff for cats and dogs |
| 02/25/2009 | EP1254106B1 Calcilytic compounds |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374844A Pyrrolopyridazinone compound |
| 02/25/2009 | CN101374824A Heterocyclic GABA-B modulators |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101374533A Use of selected lactic acid bacteria for reducing infantile colic |
| 02/25/2009 | CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 02/25/2009 | CN101374508A Novel nitrocatechol derivatives having selectin ligand activity |
| 02/25/2009 | CN101372491A Lignan sauchinone antipode, preparation thereof and liver protection application |
| 02/25/2009 | CN101371925A Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
| 02/25/2009 | CN101371924A Therapy of autoimmune disease in a patient with an inadequate response to a TNF-ALPHA inhibitor |
| 02/25/2009 | CN101371908A Gelatin-coated pill for preventing and treating calculi in vivo |
| 02/25/2009 | CN101371901A Orally taken Chinese medicinal composition for treating bad breath |
| 02/25/2009 | CN101371900A Orally taken Chinese medicinal composition for treating constipation |
| 02/25/2009 | CN101371898A Pollen cathartic medicine |
| 02/25/2009 | CN101371895A Pollen medicine for causing laxation |
| 02/25/2009 | CN101371892A Pollen medicine for causing vomiting |
| 02/25/2009 | CN101371882A Method for preparing Artemisia capillaris decoction formulation |
| 02/25/2009 | CN101371881A Chinese medicine soft capsule formulation for treating hepatosis and preparation technique thereof |
| 02/25/2009 | CN101371872A Method for producing hard capsule using Acanthopanax senticosus and schisandra chinensis |
| 02/25/2009 | CN101371871A Echinacea purpurea five-component oral spray |
| 02/25/2009 | CN101371853A Use of small intestine SP cells in preparing medicament for treating damage of intestines |
| 02/25/2009 | CN101371845A Medicament composition for curing mouth ulcer |
| 02/25/2009 | CN101371844A Sticking tablet for curing mouth ulcer using mometasone furoate as active component |
| 02/25/2009 | CN101371841A Crystallization type Entecavir formulation as well as preparation method and use thereof |
| 02/25/2009 | CN101371835A Medicament composition containing l-rebeprazole and uses thereof |
| 02/25/2009 | CN101371825A Oral sticking tablets using fluticasone propionate as active component |
| 02/25/2009 | CN101371824A Oral cavity pasting tablets using Methylprednisolone and derivatives thereof as active components |
| 02/25/2009 | CN100464186C Quality control method of compound Chinese medicine preparation |
| 02/25/2009 | CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/25/2009 | CN100463613C Preparation method for whole aloe arborensis health food |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors |
| 02/24/2009 | CA2194236C Helicobacter proteins and vaccines |
| 02/20/2009 | CA2597971A1 Method and composition for repairing epithelial and other cells and tissue |
| 02/19/2009 | WO2009023207A1 Thiazolium compounds for treating gastrointestinal complications |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022399A1 Novel microorganism having gastric juice promoting action and composition secreted by the same |
| 02/19/2009 | WO2009022346A2 Phenyl carbamates for treating gastrointestinal inflammation |
| 02/19/2009 | WO2009022066A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022065A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022064A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2008150530A3 Cripto binding molecules |
| 02/19/2009 | WO2008018827A8 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/19/2009 | US20090048579 Method and apparatus for dispensing a composition |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048435 Oligonucleotide modulation of cell adhesion |
| 02/19/2009 | US20090048342 Combination of Bioavailable Methionine With at Least One Essential Oil |
| 02/19/2009 | US20090048325 Prophylactic or Therapeutic Agent for Irritable Bowel Syndrome |
| 02/19/2009 | US20090048323 such as 1-cyclohexyl-5-{4-[dimethylamino-(3-fluorophenyl)-methyl]-cyclohexyl}-4-isobutyl-4,5-dihydro-1H-imidazole-4-carboxylic acid methyl ester, used to treat pain, depression, urinary incontinence, diarrhea, pruritus, alcohol and drug misuse, drug dependency, lethargy and/or anxiety |
| 02/19/2009 | US20090048308 VLA-4 Antagonists |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048302 Methods and compositions for the treatment of conditions related to gastric acid secretion |
| 02/19/2009 | US20090048287 Compositions useful for treating gastrointestinal motility disorders |
| 02/19/2009 | US20090048275 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 02/19/2009 | US20090048260 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048194 Vagal Afferent Neurons as Targets for Treatment |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/19/2009 | US20090048167 Disease treatment via antimicrobial peptides or their inhibitors |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047279 (R)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs |
| 02/19/2009 | US20090047266 Lipases for Pharmaceutical Use |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047223 Improvements in or Related to Organic Compoounds |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |
| 02/19/2009 | CA2691593A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/18/2009 | EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2024368A2 6,7,8,9-tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpv1 for the treatment of pain |
| 02/18/2009 | EP2024354A1 1- [ (4- [benzoyl (methyl) amino]-3- (phenyl) butyl]azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 02/18/2009 | EP2023958A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023928A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023911A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/18/2009 | EP1996210A4 Oral hygiene products and method of using the same |